Home > CPHI
Published on
Related News
We are looking for collaboration opportunites focused on pathological mechanisms common across different organs and tissues that can be translatable to skin diseases
Almirall and the Centre for Genomic Regulation (CRG) collaborate to develop and characterize novel preclinical models for non-melanoma skin cancer
Related News
Published on 28/11/2022
Almirall joins IMI project FACILITATE
We participate in FACILITATE, a patient-driven Innovative Medicines Initiative (IMI) project to enable the use of clinical trial data by study participants.
Published on 20/05/2022
Innovative therapies for vitiligo
Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo
Published on 20/03/2022
Understanding hidradenitis suppurativa
Almirall announces a collaboration with the University of Michigan to gain understanding of disease drivers in hidradenitis suppurativa
